Key points from article :
Genomenon, a U.S. company specializing in genomic analysis, has developed a new method that combines artificial intelligence with expert review to understand how genes cause diseases.
They analysed millions of scientific papers on genetics, creating a database that pinpoints specific links between genes and various illnesses.
This method also helps clarify the role of uncertain genetic changes, which could make it easier to diagnose patients using genetic testing.
Genomenon presented the results of their work at the ACMG Annual Clinical Genetics Meeting, demonstrating the power of their system.
This technology aims to make genetic medicine more precise by providing doctors and researchers with better information about the impact of specific genes.
The ultimate goal of Genomenon is to understand the entire human genome and how variations within it influence health and disease.
